Vaccine Scheduler
Romania: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Months | Years | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 4 | 6 | 11 | 12 | 5 | 6 | 11 | 14 | 18 | 26 | 27 | 45 | 64 | ≥ 65 | ||||
| Coronavirus disease (COVID-19) | COVID-19 | |||||||||||||||||
| tuberculosis | BCG7 | |||||||||||||||||
| diphtheria1 | D | D | D | D | d | |||||||||||||
| tetanus1 | TT | TT | TT | TT | TT | |||||||||||||
| pertussis2 | acP | acP | acP | acP | acp | acp8 | ||||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | ||||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | |||||||||||||||
| hepatitis B3 | HepB9 | HepB | HepB | HepB | ||||||||||||||
| pneumococcal disease4 | PCV13 | PCV13 | PCV13 | PCV13/PCV15 + PPSV23 or PCV20 | PCV13 or PCV15 or PCV20 or PPSV23 | |||||||||||||
| measles5 | MEAS | MEAS | ||||||||||||||||
| mumps5 | MUMPS | MUMPS | ||||||||||||||||
| rubella5 | RUBE | RUBE | ||||||||||||||||
| human papillomavirus infection | HPV9 (F/M) | HPV9(F) | ||||||||||||||||
| influenza6 | IIV3/IIV4/LAIV | IIV3/IIV4/QIV-HD10 | ||||||||||||||||
Version:
Footnotes:
- Risk group vaccination of dT for pregnant women. dTap is also recommended and reimbursed as a booster every 10 years from the previous dose in adults and to bone marrow transplant recipients and their family contacts who do not have specific detectable antibodies.
- dTap is also recommended and reimbursed as a booster every 10 years from the previous dose in adults and to bone marrow transplant recipients and their family contacts who do not have specific detectable antibodies.
- Recommended and reimbursed for: dialysis patients who were unvaccinated before 1995 and chronic dialysis patients who require booster doses documented serologically; people with HIV infection; people with organ, tissue, or human cell transplants; people who benefit from immunosuppressive therapy; direct contacts of confirmed hepatitis B cases; people with chronic liver diseases; asplenia; unvaccinated medical and healthcare specialist staff and healthcare auxiliary staff.
- Recommended and reimbursed for: children under 19 years old, born before 1 October 2017; people aged between 19 and 65 years, suffering of asplenia, chronic diseases or immunosuppressive diseases and specialized medical and healthcare personnel and auxiliary medical staff.
- Contacts from outbreaks of measles, mumps, rubella and flue, regardless of age. Is also recommended and reimbursed for bone marrow transplant recipients and their family contacts who do not have specific detectable antibodies.
- For risk groups established by the World Health Organization. Also recommended and reimbursed for specialized medical and healthcare personnel and auxiliary medical staff. IIV is also recommended during pregnancy.
- Administration during the 2-7 days after delivery
- Vaccination during pregnancy
- Within 24 hours after birth. In the event that the vaccine against Hepatitis B is not available, a different schedule applies for babies born of HBsAG positive mothers. More information available at: http://www.cnscbt.ro/index.php/calendarul-national-de-vaccinare
- For adults aged 45–65 years without chronic medical conditions, the influenza vaccines are 50% reimbursed. For those aged 65 years and above the vaccine is fully reimbursed.
More information available at:
http://www.cnscbt.ro/index.php/calendarul-national-de-vaccinare http://desprevaccin.ro/ https://www.colegfarm.ro/userfiles/file/Anexa%20la%20OMS%20964_2022%20_MO-Partea-I-nr.-320Bis.pdf https://legislatie.just.ro/Public/DetaliiDocument/274488
MAJOR HISTORICAL CHANGES
Measles, mumps, rubella:
1979: Measles vaccine was introduced into national children vaccination schedule for children 9-11 months of age.
1994: Second measles vaccine dose was introduced into national children vaccination schedule for children 6-7 years of age (first school grade).
2002: 1st April first measles vaccine dose was moved from 9-11 month to 12-15 months to prepare for MMR introduction.
2003: Rubella vaccination was introduced into national children vaccination schedule for girls aged 14-15 years.
2004: MMR 1 was introduced into national children vaccination schedule for children at 12-15 month of age.
2005: October, MMR 2 was introduced into national children vaccination schedule for children at 6-7 years of age (first school grade).
2015: Change to the primary infant series. Moving to a 2, 4 and 11 months schedule for DTaP-IPV-Hib-HepB instead of a 2,4,6 and 12 month schedule. introduction of hexavalent vaccines.
Other vaccines:
2008: From October 2008, DTaP replaced DTwP and IPV replaced OPV. Both DTaP and IPV receommended as a combined quadrivalent vaccine at 2, 4 and 6 months. DTaP recommended at 4 years of age replaced DTwP given at 30-35 months of age.
2010: From January 2010, the quadrivalent vaccine DTPa-IPV was replaced by the pentavalent vaccine DTPa-IPV-HibV.
Date of last update: 16 Jan. 2024